|
|
502 West Office Center Drive
Fort Washington, PA 19034 USA
phone:(215) 461-2000
fax:(215) 461-2006
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.vitaepharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Small molecule drugs in cardiovascular, metabolic diseases, cancer and dermatology. |
|
| Management |
| Jeffrey S. Hatfield, Chief Executive Officer; John J. Baldwin, Ph.D., Co-founder; Richard Gregg, Ph.D., Chief Scientific Officer; Tina Fiumenero, Chief Financial Officer; David A. Claremon, Ph.D., Vice President of Chemistry; Kevin J. Heyeck, Vice President of Business Development; Gerard M. McGeehan, Ph.D., Vice President of Discovery Biology |
| |
|
|
| |
|
| Keywords |
| small molecule, cardiovascular, metabolic, cancer, dermatology |
|
|
|
| Description |
|
Vitae Pharmaceuticals is focused on discovering, developing and commercializing innovative small molecule drugs candidates in cardiovascular and metabolic diseases, cancer and dermatology. |
|
| Products / Services |
Vitae Pharmaceuticals, Inc. has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell levels in specific cancer treatments.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members